Home and alternate-site infusion therapy is rapidly becoming a cornerstone of home-centered healthcare delivery. As payers shift care away from hospitals, specialty drug utilization expands, and patients seek more convenient treatment settings, infusion providers are taking on an increasingly strategic role across the healthcare ecosystem.
In this perspective, we examine the market forces driving growth, the operational and reimbursement complexities shaping provider performance, and the emerging care models redefining infusion therapy. We also explore how leading organizations are positioning themselves to succeed as infusion services evolve from medication delivery into coordinated specialty care.
Please complete the form to receive this white paper. Upon submission, the white paper will be sent to your inbox.
